Sideropenic anemia in patients under periodic hemodialysis treatment: efficacy and safety of oral iron treatment
Recchia, G.; Gulino, S.; Dean, P.; Prati, G.; Firpo, M.; Galvani, E.; Muolo, A.; Ancona, G.
La Clinica Terapeutica 108(5): 397-404
1984
ISSN/ISBN: 0009-9074 PMID: 6232076 Document Number: 228273
Document emailed within 1 workday
Related Documents
Tsai, J.C.; Lai, Y.H.; Tsai, Z.Y.; Chien, L.J.; Tsai, J.H. 1991: Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum Gaoxiong Yi Xue Ke Xue Za Zhi 7(3): 126-135Kochhar, P.K.; Kaundal, A.; Ghosh, P. 2013: Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial Journal of Obstetrics and Gynaecology Research 39(2): 504-510
Ohkubo, M.; Ishimitsu, T.; Kawaguchi, T.; Abe, M.; Yagi, S. 1993: Efficacy and safety of long-term erythropoietin therapy in chronic hemodialysis patients with renal anemia Nihon Jinzo Gakkai Shi 35(2): 171-177
Pagella, P.G.; Bellavite, O.; Agozzino, S.; Donà, G.C. 1984: Pharmacological and toxicological studies on an iron succinyl-protein complex (ITF282) for oral treatment of iron deficiency anemia Arzneimittel-Forschung 34(9): 952-958
Hou, C.C.; Wu, S.C.; Wu, S.C.; Chen, T.W.; Yang, W.C.; Ng, Y.Y. 1999: Is serum transferrin receptor a sensitive marker of iron repletion in patients with iron-deficiency anemia and hemodialysis patients? Zhonghua Yi Xue Za Zhi 62(4): 189-194
Stuklov, N.I.; Semenova, E.N. 2013: Iron deficiency anemia. Modern diagnostic and treatment strategy. Criteria for therapeutic efficacy Klinicheskaia Meditsina 91(12): 61-67
Köpcke, W.; Sauerland, M.C. 1995: Meta-analysis of efficacy and tolerability data on iron proteinsuccinylate in patients with iron deficiency anemia of different severity Arzneimittel-Forschung 45(11): 1211-1216
Abdullina, L.R.; Safuanova, G.Sh.; Nikulicheva, V.I.; Kamilov, F.Kh.; Ianturina, N.Kh. 2007: Time course of changes in clinical and hematological parameters, iron metabolism, and free radical lipid oxidation in patients with iron-deficiency anemia during multimodality treatment Klinicheskaia Laboratornaia Diagnostika 2007(8): 41-43
Bonanni, F.; Amedeo, A.; Barbetti, V.; Bertolazzi, R.; Cappuccino, V.; Giudici Cipriani, A.; Operto, L.; Artom, A.; Rembado, R. 1983: Evaluation of blood ferritin in sideropenic anemia and its modifications in the course of divided-dose parenteral iron therapy Minerva Medica 74(14-15): 799-803
Russo, G.; Petrucci, V.; Spaziani, M.; Zarelli, C.; Ferazzoli, F.; Scarpellini, M.G. 1985: The use of nifedipine in the treatment of hypertensive crises in patients with chronic uremia undergoing periodic hemodialysis La Clinica Terapeutica 112(1): 37-44
Satirapoj, B.; Supasyndh, O.; Choovichian, P. 2014: A comparative study of efficacy and safety of the lyophilized powder alpha-erythropoietin and the liquid form alpha-erythropoietin for hemoglobin maintenance in patients with hemodialysis treatment Journal of the Medical Association of Thailand 97(9): 899-906
Palestini, M.; Nigro, A.; Messina, A.; Vecchi, L.; Afeltra, A.; Pinto, G. 1993: The parenteral administration of essential amino acids in patients on periodic hemodialysis treatment. a pilot study La Clinica Terapeutica 143(4): 303-308
Pan, T.; Zhuang, S.; Ma, H.; Hong, K.; Tang, W. 2004: Efficacy and safety of oral vardenafil in the treatment of erectile dysfunction Zhonghua Nan Ke Xue 10(12): 955-959
Loriot, M.-A.; Beaune, P. 2007: Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety La Revue du Praticien 57(12): 1281-1286
Babak, G.I. 1983: Use of methandrostenolone in the combined treatment of iron-deficiency anemia patients Vrachebnoe Delo 11: 34-36
Hu, J.P.; Cheng, X.; Xu, X.F.; Yu, G.J.; Luo, F.; Zhang, G.S.; Yang, N.; Shen, P.; Yan, X.Y. 2016: Reactivity of patients with maintenance hemodialysis to erythropoietin in the treatment of renal anemia Journal of Biological Regulators and Homeostatic Agents 30(2): 535-540
Jacquot, C.; Berthelot, J.M.; Chiappini-Judith, D.; Ferragu-Haguet, M.; Lefebvre, A.; Masselot, J.P.; Moynot, A.; Frydman, M.O.; Peterlongo, F. 1990: Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients Nephrologie 11(1): 11-16
Stoltzfus, R.J.; Chway, H.M.; Montresor, A.; Tielsch, J.M.; Jape, J.Khatib.; Albonico, M.; Savioli, L. 2004: Low dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children Journal of Nutrition 134(2): 348-356
Haliotis, F.A.; Papanastasiou, D.A. 1998: Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children International Journal of Clinical Pharmacology and Therapeutics 36(6): 320-325
Boratyńska, M.; Szewczyk, Z.; Szepietowski, T.; Czyz, W.; Cybulski, K.; Bogucki, J.; Szczepański, J. 1990: Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis Przeglad Lekarski 47(11): 741-745